Our analysis demonstrated dysregulated genes in the endometrial cancer signaling, the PI3K/AKT pathway, the NER pathways, and the BMP pathway in the normal cohort compared to the ovarian malignancies. This evidence concerns the gene AKT1 and endometrial cancer.